TB-500 is a synthetic fragment of Thymosin Beta-4, a naturally occurring protein involved in tissue repair and cell migration
Amgen is exploring novel biologics and peptide-based therapies, including GLP-1 receptor agonists, aiming to expand treatment options for obesity and diabetes
Taking B12 supplements with meals, adjusting doses, or switching formulations can significantly reduce stomach discomfort
The transformative potential is evident in specific contexts: for patients with high cardiovascular risk, substantial obesity, and access to comprehensive care, including nutritional support, GLP-1 agonists offer unprecedented therapeutic benefits
Materials studies may also clarify stability, release, and compatibility across different laboratory formulations
J Exp Ther Oncol